Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Silo Pharma (SILO) Change in Cash (2019 - 2025)

Silo Pharma's Change in Cash history spans 7 years, with the latest figure at -$416045.0 for Q3 2025.

  • For Q3 2025, Change in Cash fell 217.33% year-over-year to -$416045.0; the TTM value through Sep 2025 reached -$943263.0, down 120.24%, while the annual FY2024 figure was $381491.0, 104.86% up from the prior year.
  • Change in Cash for Q3 2025 was -$416045.0 at Silo Pharma, down from $1.2 million in the prior quarter.
  • Across five years, Change in Cash topped out at $6.1 million in Q3 2021 and bottomed at -$6.7 million in Q1 2023.
  • The 5-year median for Change in Cash is -$416045.0 (2025), against an average of $146802.0.
  • The largest annual shift saw Change in Cash skyrocketed 3518.95% in 2021 before it crashed 1251.87% in 2023.
  • A 5-year view of Change in Cash shows it stood at -$424415.0 in 2021, then tumbled by 108.76% to -$885989.0 in 2022, then surged by 475.23% to $3.3 million in 2023, then tumbled by 128.73% to -$955091.0 in 2024, then skyrocketed by 56.44% to -$416045.0 in 2025.
  • Per Business Quant, the three most recent readings for SILO's Change in Cash are -$416045.0 (Q3 2025), $1.2 million (Q2 2025), and -$768919.0 (Q1 2025).